Thomas Watkins, Director at Horizon Pharma plc (HZNP), bought 6,000 shares at $9.76 ($59K) on 2014-08-14, disclosed to the SEC on 2015-01-26.
Open-market purchase of $59k HZNP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| VNDA | SELL | 2020-06-02 | $223K | — | Filing → |
| HZNP | BUY | 2015-08-21 | $313K | — | Filing → |
| VNDA | SELL | 2014-03-17 | $618K | — | Filing → |